|
Alexander Weis, Ph.D., Chief Executive
Officer
- Co-founder of ILEX Oncology
- Founder of Lipitek, worked with Vector Therapeutics, Sterling Winthrop,
Weizmann Institute, CTRC
- Fellow of the Royal Society of Chemistry
- South Texas Entrepreneur of the Year in 1996
- 20+ years in bio-pharmaceutical industry; over 60 publications and
28 patents
|
Supervisory Board
Timm Diestel, Chairman
Lawyer, Hamburg, Germany.
Alexander
Ruckdäschel
Venture capitalist, partner at Alphaplus-Advisors.
Dr.
Winfried Albert
Immunologist and Clinical Biochemist.
|
